Xolair
The FDA has recently announced that it was conducting a safety review of prescription asthma drug Xolair. Data from an ongoing study has suggested a link between Xolair usage and increased heart attack and stroke risk. Xolair is administered through a bi-weekly injection, and the FDA is continuing to monitor the risks of the drug.
If you or a loved one has suffered a heart attack, stroke, or other adverse cardiovascular event while taking Xolair, The Law Offices of Larry H. Parker can help. We are a highly recognized law firm with the ability and knowledge to handle your case successfully. Larry's team of pharmaceutical litigation attorneys has recovered 1 billion dollars for our clients.
To schedule a FREE, confidential, no obligation consultation, contact us via email using our case submission form or by phone at (800) 333-0000. With Larry H. Parker's team of attorneys, you aren't charged a dime if we don't get you any money. The Law Offices of Larry H. Parker accepts product liability cases throughout the United States, with offices in Long Beach, Los Angeles, Riverside, and Fresno, California and Phoenix and Tucson, Arizona.
Xolair® is a registered trademark of Novartis AG.
